Show
Sort by
-
- Journal Article
- A1
- open access
HLA-DP on epithelial cells enables tissue damage by NKp44+ natural killer cells in ulcerative colitis
-
Tofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgium cohort study
-
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
-
Vedolizumab induces endoscopic and histologic remission in patients with Crohn’s disease
-
- Journal Article
- A1
- open access
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
-
Long-term outcomes with anti-TNF therapy and accelerated step-up in the prospective pediatric Belgian Crohnʼs disease registry (BELCRO)
-
Genome-wide copy number variation scan identifies complement component C4 as novel susceptibility gene for Crohn's disease
-
Paediatric Crohn's disease : disease activity and growth in the BELCRO cohort after 3 years follow-up
-
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
-
FAPA Familial Adenomatous Polyposis Association: the Belgian polyposis registry
-
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)
-
- Journal Article
- A1
- open access
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease
-
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
-
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
-
Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection